Clinical trials
Recruiting Phase 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
62 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 6 |
| 2021 | 1 |
| 2022 | 5 |
| 2023 | 9 |
| 2024 | 14 |
| 2025 | 10 |
| 2026 | 10 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 62 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| City of Hope Medical Center | 4 |
| St. Jude Children's Research Hospital | 4 |
| National Cancer Institute (NCI) | 3 |
| Zhejiang University | 3 |
| PersonGen BioTherapeutics (Suzhou) Co., Ltd. | 2 |
| Stanford University | 2 |
| Allterum Therapeutics, Inc | 1 |
| Andrew E. Place, MD | 1 |
| Ascentage Pharma Group Inc. | 1 |
| Autolus Limited | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 62 |
| Leukemia, Myeloid, Acute | 18 |
| Myelodysplastic Syndromes | 14 |
| Lymphoma, Non-Hodgkin | 13 |
| Hematologic Neoplasms | 8 |
| Recurrence | 8 |
| Leukemia, Biphenotypic, Acute | 7 |
| Burkitt Lymphoma | 6 |
| Leukemia | 6 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 6 |
Trials
Showing 1 to 25 of 62. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.